Expert Perspectives on Hereditary Testing in Breast Cancer

Expert Perspectives on Hereditary Testing in Breast Cancer

Episodes

Specialty:

All

Year:

All

EP. 1: Genetic Risk Assessment for Breast Cancer

May 31st 2016

EP. 2: Value of Hereditary Breast Cancer Testing

May 31st 2016

EP. 3: Mutations and the Risk for Breast Cancer

May 31st 2016

EP. 4: Breast Cancer Risks: Guidelines for Genetic Testing

May 31st 2016

EP. 5: Understanding the Options in Multi-Gene Panels

May 31st 2016

EP. 6: Assessing Breast Cancer Risk: Rationale for Multigene Panel Use

May 31st 2016

EP. 7: Clinical Experience with Multi-Gene Panel Use in Breast Cancer

May 31st 2016

EP. 8: Next-Generation Sequencing in Breast Cancer

May 31st 2016

EP. 9: Breast Cancer and Genetic Counseling

May 31st 2016

EP. 10: Cost Considerations in Breast Cancer Genetic Testing

May 31st 2016

EP. 11: Communicating Breast Cancer Genetic Testing Results to Patients

May 31st 2016

Trending on OncLive

Ifinatamab Deruxtecan BLA Voluntarily Withdrawn in Previously Treated Extensive-Stage SCLC

Etentamig Improves Response and PFS vs Standard Therapies in Triple-Class Exposed Relapsed/Refractory Myeloma

Dr Voorhees on Eligibility Criteria for the CERVINO Trial in Multiple Myeloma

Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma

FDA Approves Belzutifan Plus Lenvatinib for Advanced ccRCC